302 related articles for article (PubMed ID: 34815539)
21. Marital status independently predicts survival of patients with upper urinary tract urothelial carcinoma: A population-based study.
Li K; Wang F; Wang J; Fan C; Sun J
J Cancer Res Ther; 2021 Dec; 17(7):1709-1717. PubMed ID: 35381743
[TBL] [Abstract][Full Text] [Related]
22. Value of Preoperative Neutrophil-to-Lymphocyte Ratio in Predicting Prognosis of Surgically Resectable Urinary Cancers: Systematic Review and Meta-Analysis.
Wang Z; Wang X; Wang WD; Zheng GY; Guo H; Zhang YS
Chin Med Sci J; 2020 Sep; 35(3):262-271. PubMed ID: 32972504
[TBL] [Abstract][Full Text] [Related]
23. Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A 2020 Systematic Review and Meta-analysis, and Future Perspectives on Systemic Therapy.
Leow JJ; Chong YL; Chang SL; Valderrama BP; Powles T; Bellmunt J
Eur Urol; 2021 May; 79(5):635-654. PubMed ID: 32798146
[TBL] [Abstract][Full Text] [Related]
24. Is neutrophil-to-lymphocytes ratio a clinical relevant preoperative biomarker in upper tract urothelial carcinoma? A meta-analysis of 4385 patients.
Vartolomei MD; Kimura S; Ferro M; Vartolomei L; Foerster B; Abufaraj M; Shariat SF
World J Urol; 2018 Jul; 36(7):1019-1029. PubMed ID: 29468284
[TBL] [Abstract][Full Text] [Related]
25. Ki-67 as a Prognostic Marker in Upper Urinary Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis.
Ahn C; Jeong CW; Kwak C; Kim HH; Kim HS; Ku JH
Clin Genitourin Cancer; 2018 Aug; 16(4):e831-e841. PubMed ID: 29551582
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of pretreatment Controlling Nutritional Status score in esophageal cancer: a meta-analysis.
Lv J; Chen P; Wu J; Hu C
Pathol Oncol Res; 2023; 29():1611221. PubMed ID: 37441713
[No Abstract] [Full Text] [Related]
27. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis.
Shao Y; Wu B; Jia W; Zhang Z; Chen Q; Wang D
BMC Urol; 2020 Jul; 20(1):90. PubMed ID: 32631294
[TBL] [Abstract][Full Text] [Related]
28. Prognostic role of the controlling nutritional status (CONUT) score in patients with biliary tract cancer: a meta-analysis.
Jiang H; Wang Z
Ann Med; 2023; 55(2):2261461. PubMed ID: 37751485
[TBL] [Abstract][Full Text] [Related]
29. The Controlling Nutritional Status CONUT Score in Patients With Advanced Bladder Cancer After Radical Cystectomy.
Nemoto Y; Kondo T; Ishihara H; Takagi T; Fukuda H; Yoshida K; Iizuka J; Ishida H; Tanabe K
In Vivo; 2021; 35(2):999-1006. PubMed ID: 33622895
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of the controlling nutritional status (CONUT) score in advanced urothelial carcinoma patients.
Suzuki H; Ito M; Takemura K; Nakanishi Y; Kataoka M; Sakamoto K; Tobisu KI; Koga F
Urol Oncol; 2020 Mar; 38(3):76.e11-76.e17. PubMed ID: 31864938
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Ability of Nutritional Indices for Outcomes of Bladder Cancer: A Systematic Review and Meta-Analysis.
Jiao H; Wang L; Zhou X; Wu J; Li T
Urol Int; 2023; 107(9):886-894. PubMed ID: 37643581
[TBL] [Abstract][Full Text] [Related]
32. Impact of the controlling nutritional status (CONUT) score on perioperative morbidity and oncological outcomes in patients with bladder cancer treated with radical cystectomy.
Claps F; Mir MC; van Rhijn BWG; Mazzon G; Soria F; D'Andrea D; Marra G; Boltri M; Traunero F; Massanova M; Liguori G; Dominguez-Escrig JL; Celia A; Gontero P; Shariat SF; Trombetta C; Pavan N
Urol Oncol; 2023 Jan; 41(1):49.e13-49.e22. PubMed ID: 36274030
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Impact of Nutritional Status Assessed by the Controlling Nutritional Status (CONUT) Score in Patients with Surgically Treated Renal Cell Carcinoma.
Kang HW; Seo SP; Kim WT; Yun SJ; Lee SC; Kim WJ; Hwang EC; Kang SH; Hong SH; Chung J; Kwon TG; Hoe Kim H; Kwak C; Byun SS; Kim YJ;
Nutr Cancer; 2018; 70(6):886-894. PubMed ID: 30235010
[TBL] [Abstract][Full Text] [Related]
34. Aristolochic acid-associated urinary tract cancers: an updated meta-analysis of risk and oncologic outcomes after surgery and systematic review of molecular alterations observed in human studies.
Kang YC; Chen MH; Lin CY; Lin CY; Chen YT
Ther Adv Drug Saf; 2021; 12():2042098621997727. PubMed ID: 33815744
[TBL] [Abstract][Full Text] [Related]
35. High systemic immune-inflammation index predicts poor prognosis and response to intravesical BCG treatment in patients with urothelial carcinoma: a systematic review and meta-analysis.
Liu W; Zhang Y; Wang M; Wang M; Yang Q
Front Oncol; 2023; 13():1229349. PubMed ID: 38023187
[TBL] [Abstract][Full Text] [Related]
36. Concomitant carcinoma in situ as a prognostic factor in the upper tract urothelial carcinoma after radical nephroureterectomy: A systematic review and meta-analysis.
Gao X; Ma Y; Chen G; Chen J; Li H; Li H; Wei X; Wang K
Urol Oncol; 2020 Jun; 38(6):574-581. PubMed ID: 32273049
[TBL] [Abstract][Full Text] [Related]
37. Preoperative controlling nutritional status (CONUT) score as a novel immune-nutritional predictor of survival in non-metastatic clear cell renal cell carcinoma of ≤ 7 cm on preoperative imaging.
Elghiaty A; Kim J; Jang WS; Park JS; Heo JE; Rha KH; Choi YD; Ham WS
J Cancer Res Clin Oncol; 2019 Apr; 145(4):957-965. PubMed ID: 30758671
[TBL] [Abstract][Full Text] [Related]
38. Elevated Controlling Nutritional Status (CONUT) Score is Associated with Poor Long-term Survival in Patients with Low-grade Soft-tissue Sarcomas Treated with Surgical Resection.
Liang Y; Hou T; Que Y; Zhao B; Xiao W; Zhang X; Zhou Z
Clin Orthop Relat Res; 2019 Oct; 477(10):2287-2295. PubMed ID: 31107315
[TBL] [Abstract][Full Text] [Related]
39. Impact of tumor architecture on disease recurrence and cancer-specific mortality of upper tract urothelial carcinoma treated with radical nephroureterectomy.
Fan B; Hu B; Yuan Q; Wen S; Liu T; Bai S; Qi X; Wang X; Yang D; Sun X; Song X
Tumour Biol; 2017 Jul; 39(7):1010428317710822. PubMed ID: 28714362
[TBL] [Abstract][Full Text] [Related]
40. Is radiotherapy helpful for the prognosis of upper urinary tract urothelial carcinoma? A meta-analysis.
Zhou X; Luo G
Urol Oncol; 2022 Oct; 40(10):424-433. PubMed ID: 35863956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
